Campbell Newman Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Campbell Newman Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,957	Closed	-$921K	–	110
2023 Q4	$921K	Sell	17,957 -14,869	-45%	-$781K	0.08%	90
2023 Q3	$1.91M	Hold	32,826	–	–	0.18%	54
2023 Q2	$2.1M	Hold	32,826	–	–	0.19%	51
2023 Q1	$2.28M	Hold	32,826	–	–	0.22%	48
2022 Q4	$2.36M	Hold	32,826	–	–	0.24%	42
2022 Q3	$2.33M	Hold	32,826	–	–	0.26%	41
2022 Q2	$2.53M	Hold	32,826	–	–	0.27%	40
2022 Q1	$2.4M	Hold	32,826	–	–	0.23%	47
2021 Q4	$2.05M	Hold	32,826	–	–	0.18%	60
2021 Q3	$1.94M	Hold	32,826	–	–	0.2%	58
2021 Q2	$2.19M	Sell	32,826 -6,750	-17%	-$440K	0.22%	56
2021 Q1	$2.5M	Sell	39,576 -180,444	-82%	-$11.2M	0.26%	48
2020 Q4	$13.6M	Buy	220,020 +11,307	+5%	+$695K	1.55%	30
2020 Q3	$12.6M	Buy	208,713 +1,462	+0.7%	+$88K	1.61%	30
2020 Q2	$12.2M	Buy	207,251 +80,008	+63%	+$4.79M	1.68%	30
2020 Q1	$7.09M	Buy	127,243 +726	+0.6%	+$44.4K	1.21%	31
2019 Q4	$8.12M	Buy	126,517 +94,378	+294%	+$5.41M	1.1%	32
2019 Q3	$1.63M	Hold	32,139	–	–	0.23%	52
2019 Q2	$1.46M	Hold	32,139	–	–	0.21%	55
2019 Q1	$1.53M	Hold	32,139	–	–	0.24%	51
2018 Q4	$1.67M	Hold	32,139	–	–	0.29%	49
2018 Q3	$2M	Hold	32,139	–	–	0.29%	48
2018 Q2	$1.78M	Hold	32,139	–	–	0.28%	49
2018 Q1	$2.03M	Sell	32,139 -2,310	-7%	-$149K	0.34%	47
2017 Q4	$2.11M	Hold	34,449	–	–	0.36%	45
2017 Q3	$2.2M	Sell	34,449 -850	-2%	-$49.6K	0.39%	45
2017 Q2	$1.97M	Hold	35,299	–	–	0.35%	45
2017 Q1	$1.92M	Hold	35,299	–	–	0.35%	44
2016 Q4	$2.06M	Hold	35,299	–	–	0.4%	42
2016 Q3	$1.9M	Hold	35,299	–	–	0.34%	45
2016 Q2	$2.6M	Buy	+35,299	New	+$2.49M	0.47%	39

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Campbell Newman Asset Management's BMY Position: Q1 2024 in Review

Campbell Newman Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 17,957 shares — an estimated $921K sold.

Campbell Newman Asset Management first reported a position in BMY in Q2 2016 and held it in 31 quarters. The position peaked at $13.6M in Q4 2020. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Campbell Newman Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Campbell Newman Asset Management sold 17,957 Bristol-Myers Squibb shares in Q1 2024, an estimated $921K.
Campbell Newman Asset Management first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 31 quarters.
Campbell Newman Asset Management's Bristol-Myers Squibb position peaked at $13.6M in Q4 2020.
2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Campbell Newman Asset Management's 13F filing for Q1 2024, filed 16 Apr 2024.